1-4 of 4
Qiao Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Qiao-Li Wang, Chao Ma, Chen Yuan, Qian Shi, Brian M. Wolpin, Yin Zhang, Charles S. Fuchs, Jeffrey Meyer, Tyler Zemla, En Cheng, Priya Kumthekar, Katherine A. Guthrie, Felix Couture, Philip Kuebler, Pankaj Kumar, Benjamin Tan, Smitha Krishnamurthi, Richard M. Goldberg, Alan Venook, Charles Blanke, Anthony F. Shields, Eileen M. O'Reilly, Jeffrey A. Meyerhardt, Kimmie Ng
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2621–2630.
https://doi.org/10.1158/1078-0432.CCR-23-0447
Published: 14 July 2023
View article titled, Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
Open the PDF for Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance) in another window
Includes: Supplementary data
Journal Articles

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Qiao Li, Xiuwen Guan, Shanshan Chen, Zongbi Yi, Bo Lan, Puyuan Xing, Ying Fan, Jiayu Wang, Yang Luo, Peng Yuan, Ruigang Cai, Pin Zhang, Qing Li, Dafang Zhong, Yifan Zhang, Jianjun Zou, Xiaoyu Zhu, Fei Ma, Binghe Xu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (17): 5212–5220.
https://doi.org/10.1158/1078-0432.CCR-18-4173
Published: 03 September 2019
View article titled, Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
Open the PDF for Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression

Qiao Li, Xiangming Lao, Qin Pan, Ning Ning, Ji Yet, Yingxin Xu, Shengping Li, Alfred E. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 4987–4995.
https://doi.org/10.1158/1078-0432.CCR-11-0207
Published: 31 July 2011
View article titled, Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
Open the PDF for Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression in another window
Journal Articles

Expanded Tumor-reactive CD4+ T-Cell Responses to Human Cancers Induced by Secondary Anti-CD3/Anti-CD28 Activation

Qiao Li, Senta A. Furman, Carol R. Bradford, Alfred E. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 461–469.
Published: 01 February 1999
View article titled, Expanded Tumor-reactive CD4<sup>+</sup> T-Cell Responses to Human Cancers Induced by Secondary Anti-CD3/Anti-CD28 Activation
Open the PDF for Expanded Tumor-reactive CD4<sup>+</sup> T-Cell Responses to Human Cancers Induced by Secondary Anti-CD3/Anti-CD28 Activation in another window